Tempus Compass

Contract Research Organization Services

Overview

High-touch, full-service CRO tailored to biotech

 

Bring discoveries from the lab to market through our full-service CRO, optimized for biopharma and complex oncology drug development, as Tempus Compass brings end-to-end solutions across phase I-IV of therapeutic development. From discovery research, trial design, and patient enrollment to regulatory approval and post approvals, Compass is a full-service partner that can tailor solutions to any step of your oncology drug development cycle.

Data-driven solutions
Accelerate your clinical trials with unparalleled access to real-world data, intelligent site selection, and unique enrollment solutions.

 

Deep oncology expertise
We bring our oncology expertise to guide and overcome challenges across all aspects of trial planning and execution.

 

Strong partnership and collaboration
We prioritize our customer’s success and provide comprehensive customer support and partnership through high-caliber, dedicated project teams.

Our team

Dedicated, expert teams

Hand-selected project team with proven experience and reputation.

 

Strong site relationships

Experienced monitors can build well-trained sites to get faster, cleaner data

 

Proactive management

Seasoned project leads with prior Sponsor experience

 

Strategic partner

Augment your internal team and ensure successful project and portfolio delivery

CRO oncology solutions

Tempus Compass offers full-service, scalable solutions from Phase I to Phase IV global trial management:

  • Trial feasibility and planning

  • Project management

  • Site identification and selection

  • Site start-up and regulatory review

  • Site management and monitoring

  • Safety/pharmacovigilance

  • Data management

  • Biostatistics

  • Medical writing

  • Medical affairs

  • Quality assurance

Our expertise is across a range of oncology treatment modalities:

  • Cancer vaccines

  • Adoptive cell therapies

  • Targeted therapies

  • Checkpoint modulators

  • Combination therapies

  • Antibody drug conjugates

  • Bi-specifics

  • Small-molecule

  • Large-molecule

  • Immune-oncology

And all trial designs:

  • Phase I-IV

  • Orphan designation

  • First in human

  • Modern trial designs (basket, umbrella, etc.)

  • Biomarker & companion diagnostic

  • Fast track/breakthrough therapy

  • Virtual/hybrid Trials

  • Dose escalation and expansion

  • Adaptive trials

Our impact

We have supported some of the most innovative companies from planning their first-in-human trials to the conclusion of their global, pivotal trials, market applications, and inspections.

 

What our clients are saying:

[Tempus Compass] is not a typical CRO: they are a partner committed to executing high-quality clinical trials.

[Tempus Compass] consistently demonstrates their expertise and sincere investment in the success of the study.

[Tempus Compass] is aggressive in their pursuit of achieving milestones and surpassing deadlines, and it is rare that I have asked a question that they have not already considered themselves.

This is AI-enabled precision medicine

This is the future of healthcare.